9
Apr
2025

Sterling Pharma Solutions

Exhibitor at CPHI Japan 2025 stand 5Q-23
About Us

Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years’ experience in providing small molecule API development and manufacturing services to the pharmaceutical industry, specialising in handling challenging chemistries. 

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services.

Sterling has six facilities across the UK, USA and Europe, employing 1,350+ people.
...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • GB
  • 2016
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Custom Manufacturing/Custom Synthesis
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Japan 2025
  • 09 Apr 2025 – 11 Apr 2025
  • East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
  • Visit us at stand 5Q-23

Products Featured at CPHI Japan 2025

  • ADC development

    Product ADC development

    More than 30 years' experience in ADC development and specialist bioconjugation services.
  • ADC manufacturing

    Product ADC manufacturing

    Sterling’s dedicated bioconjugation facility, located in Deeside, Wales, can handle a variety of batch sizes to support cGMP clinical and preclinical manufacture of antibody drug conjugates (ADCs) and bioconjugates. Through our integrated global network, we are also capable of manufacturing linker payloads...
  • Chemistry Services

    Product Chemistry Services

    Sterling offers a range of early phase chemistry services to ensure quality, purity and efficacy at every stage in your small molecule project. These services include: Drug discovery A comprehensive service to increase the chance of success from the start. We provide close scientific collaboration and exp...
  • Small molecule API development

    Product Small molecule API development

    At Sterling we have extensive API Development capabilities ranging from route scouting and design, through to process optimisation and full validation support, including quality by design (QbD). As a PDMO®, science is at the core of everything that we do and underpins our approach to API Development, coupl...
  • Small molecule API manufacturing

    Product Small molecule API manufacturing

    Scalable small molecule API manufacturing, from grams to tons: Our flexible and tailored approach to API manufacturing enables us to support even the most specialised and complex project requirements. Our facilities in the UK, EU and US are equipped with state-of-the-art API manufacturing equipment to supp...